A framework for industrial systems modeling and simulation

To successfully compete in a global market, manufacturing production systems are being forced to reduce time to market and to provide improved responsiveness to changes in market conditions. The organizations that comprise the business links in the production system must constantly make tradeoffs between time and cost in order to achieve a competitive but quick response to consumer demand. Due to the inherent uncertainty of consumer demand, these tradeoffs are, by definition, made with incomplete information and can incur significant financial and competitive risk to the organization. Partnerships between organizations are a mechanism for increasing the information in the decision making process by combining information from the two partners. Partnerships are inherently difficult to implement due to trust issues. A mechanism for investigating and validating the mutual benefit to partnering would be useful in designing and implementing partnerships. This paper describes the development of a software framework for industrial systems modeling and simulation. The framework provides a mechanism for investigating changes to industrial systems in a manner which minimizes the effort and computational power needed to develop focused simulations. The architecture and it`s component parts are described

Exendin-4 effects on islet volume and number in mouse pancreas

The aim of this study was to evaluate Exendin-4 (EX-4) effects on islet volume and number in the mouse pancreas. Thirty-two healthy adult male NMRI mice were randomly divided into control and experimental groups. EX-4 was injected intraperitoneally (i. p.) at doses of 0.25 (E1 group), 0.5 (E2 group), and 1 µg/kg (E3 group), twice a day for 7 consecutive days. One day after the final injection, the mice were sacrificed, and the pancreas from each animal dissected out, weighed, and fixed in 10% formalin for measurement of pancreas and islet volume, and determination of islet number by stereological assessments. There was a significant increase in the weight of pancreases in the E3 group. Islet and pancreas volumes in E1 and E2 groups were unchanged compared to the control group. The E3 group showed a significant increase in islet and pancreas volume (P < 0.05). There were no significant changes in the total number of islets in all three experimental groups. The results revealed that EX-4 increased pancreas and islet volume in non-diabetic mice. The increased total islet mass is probably caused by islet hypertrophy without the formation of additional islets

Images in Medicine - A Variant of Poland Syndrome

A 30-year-old man presented with aesthetic complaints of weakness on the right side along with maldevelopment of right hand since birth. The birth history was uneventful. There was no history of exposure to teratogenic drugs. Seven other siblings were normal. The parents did not have a similar defect

Images in Medicine - A Variant of Poland Syndrome

A 30-year-old man presented with aesthetic complaints of weakness on the right side along with maldevelopment of right hand since birth. The birth history was uneventful. There was no history of exposure to teratogenic drugs. Seven other siblings were normal. The parents did not have a similar defect

Organoleptic assessment of halitosis for dental professionals - general recommendations

An organoleptic assessment of an odor is defined as a method that can measure the strength of target odors and expresses the value in terms of a point or number with reference to a pre-defined organoleptic scale. Organoleptic assessments are performed using different scales and are used widely in industry (e.g. for measuring the effectiveness of anti-odor agents), in research (to discover relationships between bad breath and microbiology of the tongue, or the generation of particular volatile compounds), but it is also a prerequisite for the diagnosis of halitosis in individual patients required before directing appropriate treatment. An organoleptic assessment of halitosis patients may be carried out in specialized institutions but--based on the fact that in most cases the odor originates from oral structures--also by dental professionals including general dental practitioners (GDPs). Thus, this paper describes the scientific background for recommendations on how a GDP or dental hygienist or general practitioner with cases of bad breath should use organoleptic methods as a valid approach to assess malodor in patients, with a view to diagnosis and treatment, and subsequent treatment monitoring

Study on the organoleptic intensity scale for measuring oral malodor

The 0-5 organoleptic scale is used widely in breath research and in trials to measure the efficacy of anti-odor agents. However, the precise relationship between odor scores and gas concentrations of target odorants is unknown. The purpose of this study was to relate mean organoleptic scores from odor judges (n = 7) for pure odorants (n = 8) representative of those found in oral malodor. Judges used a common 0-5 scale to report the odor intensity of sample sets in random order of concentration. Regression analysis of data showed that odor score was proportional to the log concentration of odorant, and comparison of slopes showed H2S to be the most significant in terms of odor power. Detection thresholds (mol.dm-3) were: Skatole (7.2 × 10 -13) < methylmercaptan (1.0 × 10-11) < trimethylamine (1.8 × 10-11) < isovalerate (1.8 × 10-11) < butyrate (2.3 × 10-10) < hydrogen sulphide (6.4 × 10-10) < putrescine (9.1 × 10 -10) < dimethyl disulphide (5.9 × 10-8). The study demonstrates the exponential nature of the olfactory response and shows that any single compound's contribution to malodor depends on odor power and threshold in addition to concentration

Halitosis management by the general dental practitioner--results of an international consensus workshop

Clinical investigations on patients suffering from halitosis clearly reveal that in the vast majority of cases the source for an offensive breath odor can be found within the oral cavity (90%). Based on these studies, the main sources for intra-oral halitosis where tongue coating, gingivitis/periodontitis or a combination of the two. Thus, it is perfectly logical that general dental practitioners (GDPs) should be able to manage intra-oral halitosis under the conditions found in a normal dental practice. However, GDPs who are interested in diagnosing and treating halitosis are challenged to incorporate scientifically based strategies for use in their clinics. Therefore, the present paper summarizes the results of a consensus workshop of international authorities held with the aim to reach a consensus on general guidelines on how to assess and diagnose patients' breath odor concerns and general guidelines on regimens for the treatment of halitosis.status: publishe